oseltamivir has been researched along with bms-650032 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Aron, SL; Fay, EJ; Langlois, RA; Plemper, RK; Stone, IA; Waring, BM | 1 |
2 other study(ies) available for oseltamivir and bms-650032
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Engineered Small-Molecule Control of Influenza A Virus Replication.
Topics: A549 Cells; Animals; Antiviral Agents; Dogs; HEK293 Cells; Humans; Influenza A virus; Isoquinolines; Madin Darby Canine Kidney Cells; Oseltamivir; Protein Engineering; Recombinant Fusion Proteins; Small Molecule Libraries; Sulfonamides; Virus Replication | 2019 |